Clinical Trial Update: A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety, tolerability, pharmacokinetics, and antiviral activity of ABT-450/r in combination with ABT-072 and ribavirin for hepatitis C (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ABT-072
• ABT-450/r (paritaprevir/ritonavir) (paritaprevir/ritonavir)
• Ribavirin (ribavirin)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Hepatitis C, HCV | Phase 2 | Status: COMPLETED | Results posted: 2015-01-08